BDBM50010178 CHEMBL2370398::[4-Acetyl-16-acetylamino-13-(2-carbamimidoyl-ethyl)-13-(2-guanidino-ethyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid

SMILES CC(=O)N[C@@H]1CSSC(C)(C)[C@H](C(C)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@](CCN=C(N)N)(CCC(=N)N)NC1=O

InChI Key InChIKey=CSXNTMKSHSPCSH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50010178   

TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50010178BDBM50010178(CHEMBL2370398 | [4-Acetyl-16-acetylamino-13-(2-car...)
Affinity DataIC50: 8.20E+4nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed